Use of lacritin in promoting ocular cell survival

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2566607

The present invention relates to the use of lacritin, and fragments, derivatives, and homologs thereof, and nucleic acid sequences encoding that protein. The invention relates to the use of lacritin as a growth factor human corneal epithelial cells and other select epithelial cells. The invention also relates to the use of lacritin in promoting ocular cell survival in response to an insult or injury, in protecting against ocular inflammation, and in promoting ocular wound repair.

L'invention concerne l'utilisation de la lacritine, de fragments, de dérivés et d'homologues de celle-ci, ainsi que des séquences nucléotidiques codant pour cette protéine. Elle porte aussi sur l'utilisation de la lacritine en tant que facteur de croissance pour les cellules épithéliales de la cornée et d'autres cellules épithéliales choisies. L'invention se rapporte également à l'utilisation de la lacritine dans la promotion de la survie de cellules oculaires en réponse à une agression ou à une lésion, dans la protection contre l'inflammation oculaire et dans la promotion de la cicatrisation oculaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of lacritin in promoting ocular cell survival does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of lacritin in promoting ocular cell survival, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lacritin in promoting ocular cell survival will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1715138

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.